List of insiders holdings for NEUROCRINE BIOSCIENCES INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ROBERTS BRYAN E 10% Owner | 2010-01-05 16:10:15 | 0 4,784,689 | 4,784,689 | Form 3/A |
| Hove Anders D 10% Owner | 2010-01-05 16:08:57 | 0 4,784,689 | 4,784,689 | Form 3/A |
| VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC Hove Anders D ROBERTS BRYAN E VHCP Management LLC 10% Owner | 2013-02-14 16:12:40 | 2,221,946 0 | 2,221,946 | Form 13G |
| GORMAN KEVIN CHARLES Chief Executive Officer | 2024-02-15 17:43:40 | 649,655 0 | 649,655 | Form 4 |
| CAMPBELL D BRUCE Senior Vice President | 2003-05-27 17:31:27 | 223,704 0 | 223,704 | Form 4 |
| Coughlin Timothy P Chief Financial Officer | 2017-02-08 19:39:04 | 137,961 0 | 137,961 | Form 4 |
| RANIERI RICHARD J Sr. VP, Human Resources | 2008-02-29 17:16:06 | 130,000 0 | 130,000 | Form 4 |
| LYONS GARY A Director | 2024-08-15 17:21:58 | 119,047 0 | 119,047 | Form 4 |
| THOMAS CYNTHIA J VP, Human Resources | 2004-03-03 17:19:48 | 113,670 0 | 113,670 | Form 3 |
| Lippoldt Darin Chief Legal Officer | 2024-08-05 17:18:32 | 83,112 0 | 83,112 | Form 4 |
| Onyia Jude Chief Scientific Officer | 2024-02-15 17:48:20 | 77,957 0 | 77,957 | Form 4 |
| BENEVICH ERIC Chief Commercial Officer | 2024-04-17 17:19:53 | 67,070 0 | 67,070 | Form 4 |
| OBrien Christopher Flint Former Chief Medical Officer | 2018-02-07 18:08:56 | 65,196 0 | 65,196 | Form 4 |
| CONLON PAUL J Vice President Research (Biol) | 2003-12-18 13:56:15 | 0 57,335 | 57,335 | Form 4 |
| VALEUR JENSEN MARGARET E EVP and General Counsel | 2011-09-01 17:27:30 | 50,000 0 | 50,000 | Form 4 |
| Lloyd-Smith Malcolm Chief Integration Officer | 2023-02-08 19:35:55 | 42,337 0 | 42,337 | Form 4 |
| RASTETTER WILLIAM H Director | 2024-08-16 17:00:51 | 37,491 0 | 37,491 | Form 4 |
| Grigoriadis Dimitri E. Chief Research Officer | 2022-02-02 20:04:40 | 37,065 0 | 37,065 | Form 4 |
| ROBERTS EIRY Chief Medical Officer | 2024-11-12 17:58:47 | 32,326 0 | 32,326 | Form 4 |
| ABERNETHY MATT Chief Financial Officer | 2024-08-15 17:12:01 | 31,528 0 | 31,528 | Form 4 |
| Gros David-Alexandre C President & COO | 2017-02-08 19:42:09 | 25,000 0 | 25,000 | Form 4 |
| WIERENGA WENDALL EVP, Research & Development | 2006-01-23 20:15:00 | 25,000 0 | 25,000 | Form 4 |
| MITCHELL W THOMAS Director | 2016-05-24 15:41:49 | 25,000 0 | 25,000 | Form 4/A |
| Delaet Ingrid Chief Regulatory Officer | 2024-08-15 17:06:01 | 24,556 0 | 24,556 | Form 4 |
| SHERWIN STEPHEN A Director | 2024-11-07 19:42:38 | 24,504 0 | 24,504 | Form 4 |
| PAN HENRY Executive VP and CMO | 2005-06-06 13:35:43 | 22,000 0 | 22,000 | Form 4 |
| Cooke Julie Chief Human Resources Officer | 2024-08-05 17:40:36 | 18,202 0 | 18,202 | Form 4 |
| NEUROCRINE BIOSCIENCES INC Director | 2015-04-09 16:22:08 | 16,030 0 | 16,030 | Form 4 |
| Gano Kyle Chief Executive Officer | 2024-11-01 19:52:05 | 15,799 0 | 15,799 | Form 4 |
| STEINMAN LAWRENCE Director | 2005-03-02 14:24:21 | 15,500 0 | 15,500 | Form 4 |
| VALE WYLIE W Director | 2011-05-25 19:13:39 | 15,000 0 | 15,000 | Form 4 |
| MOLLICA JOSEPH A Director | 2017-06-08 18:30:31 | 15,000 0 | 15,000 | Form 4 |
| LITTLE ROBERT J SVP, Commercial Operations | 2005-02-22 17:19:47 | 15,000 0 | 15,000 | Form 4 |
| Nevinny Corinne H Director | 2018-05-25 19:56:48 | 12,500 0 | 12,500 | Form 4 |
| ADAMS ADRIAN Director | 2006-06-30 17:30:18 | 12,000 0 | 12,000 | Form 4 |
| Sandrock Alfred Director | 2019-05-23 17:46:16 | 10,000 0 | 10,000 | Form 4 |
| POON CHRISTINE A Director | 2024-05-23 18:45:31 | 4,417 0 | 4,417 | Form 4 |
| Sharp Shalini Director | 2024-05-23 18:34:03 | 4,417 0 | 4,417 | Form 4 |
| Norwalk Leslie V Director | 2024-05-23 18:02:27 | 4,417 0 | 4,417 | Form 4 |
| Mercier Johanna Director | 2024-05-23 17:59:15 | 4,417 0 | 4,417 | Form 4 |
| Bozigian Haig P. Chief Development Officer | 2021-03-29 06:12:25 | 3,504 0 | 3,504 | Form 4/A |
| SAUNDERS JOHN Vice President Research (Chem) | 2003-12-19 14:48:22 | 2,916 0 | 2,916 | Form 4 |
| POPS RICHARD F Director | 2024-05-23 18:26:06 | 2,869 0 | 2,869 | Form 4 |
| MORROW GEORGE J Director | 2024-05-23 18:21:21 | 2,869 0 | 2,869 | Form 4 |
| Boyer David W. Chief Corp. Affairs Officer | 2024-10-07 16:33:13 | 377 0 | 377 | Form 4 |
| HAWRAN PAUL W Senior Advisor | 2006-09-20 16:33:13 | 0 0 | 0 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2013-02-14 15:26:39 | 0 0 | 0 | Form 13G |